Systemic light-chain (AL) amyloidosis is a rare and life-threatening disease characterised by excessive light-chain depositions in the tissues and organs. The toxic light-chain paraprotein originates from clonal plasma cells or from a small B‑cell clone [ 1 ]. The most commonly involved organs are the heart, kidneys and the liver along with the gastrointestinal tract and the peripheral and autonomic nervous systems. The pattern of organ involvement determines the clinical presentation, and the symptoms are often very unspecific: fatigue, dyspnea, ankle and leg edema, weight loss, diarrhea, obstipation and orthostatic hypotension [ 2 , 3 ]. However, there are some specific but rare signs and symptoms suggesting the presence of amyloidosis. These include periorbital ecchymosis, an enlarged tongue, bilateral carpal tunnel syndromes and nail dystrophy [ 2 ].
No takes yet. Share an insight, caveat, or question.
Hermine Agis (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: